Characteristic | Value |
---|---|
No. of patients | 33 |
Age (y) | |
Meana | 74.4 ± 6.7 |
Range | 58- 84 |
Lymphadenopathy at US | |
Negative | 4 |
Positive | 29 |
Clinical T stage | |
T2 | 2 (6.1) |
T3 | 11 (33.3) |
T4 | 20 (60.6) |
Clinical N stage | |
N0 | 14 (42.4) |
N1 | 16 (48.5) |
N2 | 2 (6.1) |
N3 | 1 (3.0) |
Clinical stage | |
IIB | 4 (12.12) |
IIIA | 7 (21.21) |
IIIB | 20 (60.61) |
IIIC | 1 (3.03) |
IV | 1 (3.03) |
Histologic type | |
Ductal | 26 (78.8) |
Lobular | 5 (15.2) |
Other | 2 (6.1) |
Histologic grade | |
1 | 1 (3.0) |
2 | 26 (78.8) |
3 | 5 (15.2) |
missing | 1 (3.0) |
Breast Surgery | |
Breast-conserving surgery | 4 (87.9) |
Total mastectomy | 29 (12.1) |
Lymph node surgery | |
SLNB | 7 (21.21) |
ALND | 18 (54.55) |
Both | 8 (24.24) |
ypT stage | |
Tis | 1 (3.0) |
T1 | 8 (24.2) |
T2 | 19 (57.6) |
T3 | 3 (9.1) |
T4 | 2 (6.1) |
ypN stage | |
N0 | 6 (18.2) |
N1 | 17 (51.5) |
N2 | 9 (27.3) |
N3 | 1 (3.0) |